Cadherin 26 is an alpha integrin-binding epithelial receptor regulated during allergic inflammation

Area of Science:

• Immunology
• Cell Biology
• Gastroenterology

Background:

• Cadherins (CDH) are crucial for cellular processes in inflammation, including adhesion, migration, and differentiation.
• The specific role of cadherin 26 (CDH26) in allergic responses remained uncharacterized prior to this study.

Purpose of the Study:

• To investigate the function and immunomodulatory properties of the uncharacterized cadherin 26 (CDH26) in allergic gastrointestinal responses.
• To explore the potential of CDH26 as a therapeutic target.

Main Methods:

• Biochemical assays to assess homotypic binding and interaction with catenin family members.
• In vitro assays to evaluate CDH26's interaction with integrins (α4β7, αE, α4).
• Functional assays using CDH26-Fc to assess its impact on human CD4+ T-cell activation and cytokine secretion (IL-2).

Main Results:

• CDH26 is highly expressed by epithelial cells in human allergic gastrointestinal tissue.
• CDH26 mediates calcium-dependent cell adhesion via homotypic binding and catenin interactions.
• CDH26 enhances cell adhesion to integrin α4β7 and binds to αE and α4 integrins.
• CDH26-Fc inhibits activation of human CD4+ T cells and IL-2 secretion.

Conclusions:

• Cadherin 26 is a novel functional cadherin involved in allergic responses.
• CDH26 possesses unique immunomodulatory properties by regulating leukocyte adhesion and T-cell activation.
• CDH26-Fc represents a potential therapeutic strategy for immune regulation in allergic conditions.